Risk of Appropriate Implantable Cardioverter-Defibrillator Therapies and Sudden Cardiac Death in Patients With Heart Failure With Improved Left Ventricular Ejection Fraction

This publication has 24 references indexed in Scilit:

• Generator replacement is associated with an increased rate of ICD lead alerts
  Heart Rhythm, 2014
• Association Between Prophylactic Implantable Cardioverter-Defibrillators and Survival in Patients With Left Ventricular Ejection Fraction Between 30% and 35%
  JAMA, 2014
• Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures
  Circulation, 2010
• Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy
  JACC, 2008
• Effect of Cardiac Resynchronization Therapy on Myocardial Gene Expression in Patients with Nonischemic Dilated Cardiomyopathy
  Journal of Cardiac Failure, 2007
• Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
  New England Journal of Medicine, 2005
• Measuring inconsistency in meta-analyses
  BMJ, 2003
• β-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure
  Circulation, 2003
• Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
  New England Journal of Medicine, 2002
• Improvement of Postreceptor Events by Metoprolol Treatment in Patients With Chronic Heart Failure
  JACC, 1997